Wedbush Lowers G1 Therapeutics (NASDAQ:GTHX) Price Target to $4.00
G1 Therapeutics (NASDAQ:GTHX – Free Report) had its target price lowered by Wedbush from $5.00 to $4.00 in a research report sent to investors on Tuesday morning, Benzinga reports. The brokerage currently has an outperform rating on the stock. Wedbush also issued estimates for G1 Therapeutics’ FY2025 earnings at ($0.52) EPS, FY2026 earnings at ($0.40) […]
More Stories
Brookfield Property Partners L.P. (NASDAQ:BPYPN) Short Interest Up 76.2% in December
Brookfield Property Partners L.P. (NASDAQ:BPYPN – Get Free Report) was the recipient of a significant growth in short interest during...
ProShares UltraPro Short Dow30 (NYSEARCA:SDOW) Shares Gap Down – Should You Sell?
ProShares UltraPro Short Dow30 (NYSEARCA:SDOW – Get Free Report)’s stock price gapped down prior to trading on Wednesday . The...
Rockland Trust Co. Sells 5,329 Shares of Walmart Inc. (NYSE:WMT)
Rockland Trust Co. decreased its position in Walmart Inc. (NYSE:WMT – Free Report) by 4.4% during the fourth quarter, according...
Pagaya Technologies (NASDAQ:PGY) Shares Gap Up – Time to Buy?
Pagaya Technologies Ltd. (NASDAQ:PGY – Get Free Report) shares gapped up prior to trading on Wednesday . The stock had...
Quantum Computing (NASDAQ:QUBT) Sees Unusually-High Trading Volume – Time to Buy?
Quantum Computing Inc. (NASDAQ:QUBT – Get Free Report) saw unusually-strong trading volume on Wednesday . Approximately 32,599,659 shares were traded...
Cliftonlarsonallen Wealth Advisors LLC Has $137.84 Million Holdings in iShares S&P 500 Growth ETF (NYSEARCA:IVW)
Cliftonlarsonallen Wealth Advisors LLC lowered its stake in iShares S&P 500 Growth ETF (NYSEARCA:IVW – Free Report) by 7.0% during...